Subscribe To

Price Alert Latest News Economic Calendar News

ISPC / iSpecimen to Report Fourth Quarter and Full Year 2022 Results on March 14, 2023

LEXINGTON, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today announced that it will report its financial results for the fourth quarter and full year ended December 31, 2022, before the markets open on Tuesday, March 14, 2023. Read More

Demo Live Account See Partner Details

Content Topics

Ispecimen

Report

Fourth

Quarter

Full

Year

2022

Results

March

Stock

ISPC

Posted: Feb 28 2023, 16:02

Author Name: GlobeNewsWire

ISPC News

By Seeking Alpha
November 3, 2023

iSpecimen Inc. (ISPC) Q3 2023 Earnings Call Transcript

iSpecimen Inc. (NASDAQ:ISPC ) Q3 2023 Earnings Conference Call November 2, 2023 8:30 AM ET Company Participants Phil Carlson - Investor Relations, KCS

By Seeking Alpha
August 5, 2023

iSpecimen Inc. (ISPC) Q2 2023 Earnings Call Transcript

iSpecimen Inc. (NASDAQ:ISPC ) Q2 2023 Earnings Conference Call August 2, 2023 8:30 AM ET Company Participants Phil Carlson - Investor Relations, KCSA

By Seeking Alpha
May 6, 2023

iSpecimen Inc. (ISPC) Q1 2023 Earnings Call Transcript

iSpecimen Inc. (NASDAQ:ISPC ) Q1 2023 Results Conference Call May 4, 2023 8:30 AM ET Company Participants Tracy Curley - Chief Executive Officer Benja

By GlobeNewsWire
April 24, 2023

iSpecimen to Participate in the Aegis Virtual Conference on May 4, 2023

LEXINGTON, Mass., April 24, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketpl

By Seeking Alpha
March 14, 2023

iSpecimen Inc. (ISPC) Q4 2022 Earnings Call Transcript

iSpecimen Inc. (NASDAQ:ISPC ) Q4 2022 Earnings Call Transcript March 14, 2023 8:30 AM ET Company Participants Allison Soss - Investor Relations-KCSA S

By Proactive Investors
March 14, 2023

iSpecimen sees 4Q revenue rise by 28% as it focuses on its supplier network and fulfillment efficiency

iSpecimen Inc said its revenue jumped 28% year-over-year in the fourth quarter as it made quick improvements to supplier utilization rates to boost o

By GlobeNewsWire
February 28, 2023

iSpecimen to Report Fourth Quarter and Full Year 2022 Results on March 14, 2023

LEXINGTON, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplac

By Seeking Alpha
November 8, 2022

iSpecimen Inc. (ISPC) Q3 2022 Earnings Call Transcript

iSpecimen Inc. (NASDAQ:ISPC ) Q3 2022 Earnings Conference Call November 8, 2022 8:30 AM ET Company Participants Allison Soss - IR Tracy Curley - Inter

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.